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Introduction
The purpose of this study is to evaluate the efficacy of a telephone-delivered cognitive behavioral treatment (T-CBT) in Veterans with a history of traumatic brain injury (TBI) for the treatment of chronic pain in a randomized controlled trial (RCT). Specifically, the RCT will examine the immediate (at the end of treatment) and long-term (6-months from randomization) efficacy of T-CBT on average pain intensity (primary outcome), and pain interference, sleep, depression, global impression of change, and life satisfaction (secondary outcomes) relative to a telephone-delivered pain psycho-educational active control condition (T-Ed) designed to control for time, dose, attention, and other nonspecific therapeutic effects such as therapeutic alliance. The study uses a 2-group parallel design. The sample will include 160 OEF/OIF Veterans with a history of TBI and chronic pain recruited from the VA Puget Sound Health Care System (VAPSHCS).
Body

Development:
The study received full approval from both the Veterans Affairs Puget Sound Health Care System's (VAPSHCS) Research We anticipate that the study will receive full HRPO IRB approval in November 2013.
The study PI has convened study meetings with study investigators on a bi-weekly basis as well as weekly meetings with the PI, the VA PI and key staff members to attend to pertinent development and preparation topics throughout Year 1. We have constructed and tested databases for session data and tracking. In addition, study personnel have finalized recruitment, enrollment and randomization procedures.
We determined that a subcontract with the VA was needed to hire appropriate study personnel and was agreed to by all parties. A revised budget and subcontract budget were submitted to and approved by the CDMRP.
Preparation:
Study personnel have obtained a Certificate of Confidentiality (CoC) from the National Institutes of Health (NIH). In addition, study personnel are finalizing study treatment manuals and participant workbooks. Study personnel have purchased all major supplies for the study. The VAPSHCS research coordinator and assistant have been trained in study procedures. Study personnel have also opened a checking account for human subject payments as well as acquired cell phone plans that will be used by study clinicians during treatment.
Formative Evaluation:
The study PI and VA PI have met with VAPSHCS medical providers to strategize the implementation of advisory group meetings with both providers and VA patients. The dual purpose of these meetings will be a) to collect data regarding current practice of pain treatment and b) identify current barriers to treatment for the study population.
Problems Encountered: Considerable effort and time were expended to submit the VA IRB application. The length of time required to submit the application has caused a delay in subject recruitment and enrollment by approximately 1-2 months. In addition, it took the VAPSHCS IRB committee a considerable amount of time to review the application; study personnel submitted the application in early January, with final approval taking place August 22, 2013 . We anticipate that the length of time the VAPSHCS IRB reviewed the application (almost eight months) may cause a potential delay in subject recruitment and enrollment by an additional 3-4 months.
We believe we will still be able to achieve our enrollment goals despite these delays given a) the research team consists of members with extensive experience in subject recruitment, b) the expressed commitment by VAPSHCS providers to help study personnel achieve their recruitment goals, and 3) the large number of patients within the VAPSHCS that we project to be eligible and willing to participate.
Key Research Accomplishments
Recruitment, enrollment and data collection have not commenced yet given the delays in obtaining full IRB approval from all responsible institutions. Given that the study materials have been prepared, we are using our study clinician time to assist in producing possible publications from existing data on TBI and subsequently relevant to the current study.
Reportable Outcomes
As mentioned above, recruitment, enrollment and data collection have not commenced yet given the delays in obtaining full IRB approval from all responsible institutions. We have submitted one paper based on previously collected data, but relevant to our current study: Research Method/Design: Longitudinal survey design with 1-year follow up. Setting: Data were collected during inpatient rehabilitation and in the community at one year after injury. Participants: The participants were 158 persons admitted to inpatient rehabilitation following moderate to severe TBI. Interventions: Not applicable. Main Outcome Measures: Depression was assessed with the Patient Health Questionnaire (PHQ-9); pain was assessed with a numerical rating scale (0= no pain to 10= worst pain); participants who reported average pain ≥ 4 were classified as having pain and participants with PHQ-9 scores ≥ 10 were classified as depressed. Results: Both pain and depression were more prevalent at baseline assessment (pain: 70%; depression: 31%) than at year 1 (pain: 34%; depression: 22%). Comorbid pain and depression declined from 27% at baseline to 18% at year 1. Pain was significantly associated with depression at baseline (RR: 2.62, p = .003) and at year1 (RR: 7.98, p < .001). Conclusions/Implications: Pain and depression are common and frequently co-occur in persons with TBI. Whereas their frequency declined over the first year following injury, the strength of their association increased. Assessment and treatment of both conditions simultaneously may lead to improved outcomes, both early after TBI as well as over time.
See appendices for full manuscript.
Conclusion
We plan to make the following progress in the 1 st quarter of the 2 nd year of this research study.
Development:
Study personnel plan to obtain USAMRMC HRPO approval to engage in human subjects research during the next reporting period. Study investigators and study personnel will continue to meet on a regular basis to discuss pertinent matters including recruitment and enrollment strategies.
Preparation: Study personnel will order study materials including treatment workbooks from UW Publication Services. Finally, study personnel will implement a 'Kick-Off' meeting once recruitment and enrollment begins.
Participant Enrollment/Data Acquisition: Study personnel will begin to recruit and enroll an average of about 6-8 subjects per month with recruitment and enrollment planned to start in Month 14. Study personnel will also commence random assignment of subjects to treatment intervention, and conduct treatment with subjects. Further, study personnel will begin collecting study data from subjects both in-person and via telephone. The study PI and investigators will provide ongoing supervision to research and clinical staff, as well as facilitate regular meetings with research staff and investigators to address enrollment issues.
Operations and Maintenance: Dr. Hoffman, Dr. Williams and Mr. Gertz will monitor study personnel performance to ensure adherence to procedures. In addition, Drs. Hoffman and Ehde will commence weekly meetings with study clinicians to address any clinical issues that may arise during treatment.
Data Management and Analysis: Study personnel will complete database development as well as commence data entry and routine data checking.
Formative Evaluation: The study PI and study personnel will consult with the Polytrauma and Blast-Related Quality Enhancement Research Initiative (QUERI) group and Tele-mental Health at VAPSHCS to assess important factors related to implementation. Further, study personnel will conduct advisory group meetings with both providers and VA patients to collect data regarding current practice of pain treatment and identify current barriers to treatment for the study population.
References
There are no references pertinent to this report.
Appendices
We have submitted one paper based on previously collected data, but relevant to our current study: We have also included a Quad Chart for this particular study as requested by the CDMRP. Org: University of Washington Award Amount: $3,085,185
Planned Recruitment
Study/Product Aim(s)
• We will evaluate the efficacy of telephone-delivered cognitive behavioral therapy (T-CBT) for reducing average pain intensity relative to telephone-delivered education intervention (T-Ed) in Veterans with a history of TBI.
• We will determine the efficacy of T-CBT relative to T-Ed in reducing pain interference, sleep problems, and depression, as well as improving global impression of change and life satisfaction.
• We will determine whether treatment effects are maintained 6 months after randomization.
• We will conduct a formative evaluation to identify key factors relevant to future dissemination and implementation of the intervention into the VA.
Approach
The sample will include 160 OEF/OIF/OND Veterans with a history of TBI and chronic pain recruited from the VA Puget Sound Health Care System (VAPSHCS). Participants will be randomized to either T-CBT or T-Ed (2 group parallel design). Each treatment will consist of eight 60-minute sessions conducted over the telephone over 8-12 weeks. Information about pain and the other commonly co-occurring conditions described above will be collected before, mid treatment, post treatment and at 6 months following randomization. 
Goals
Subjects Study Month
Both pain and depression are common among persons who have experienced moderate to severe traumatic brain injury (TBI). Estimated rates of major depressive disorder in the year following TBI range from 26 to 53%, 1-3 which stands in contrast to a 12-month prevalence of 6.7% in the general adult population. 4 Likewise, while prevalence estimates of chronic pain vary depending on how pain is assessed, there is evidence that chronic pain may be more prevalent among persons with history of TBI than the general population. A review of 23 studies examining chronic pain after TBI suggested a point prevalence of 57.8% (95% CI: 55.5%-60.2%) for chronic headaches when combining civilian and military samples. 5 The same review estimated a prevalence of 51.5% for general chronic pain among civilian (i.e., non-military)
persons who have experienced TBI. The prevalence of chronic pain is somewhat lower in the general adult population, ranging from 37 to 43%. 6, 7 Although persons with a history of moderate to severe TBI appear to bear an increased burden of both depressive symptoms and chronic pain relative to the general populations, there is little research examining the cooccurrence of depression and pain in this population.
Existing literature on depression and pain in the general population as well as in other neurological groups (e.g., multiple sclerosis 8 ), documents significant comorbidity between these conditions. 9,10 This co-occurrence may result because depression and chronic pain interact so as to exacerbate each other. 9 Investigators have proposed a variety of causal mechanisms for this reciprocal relationship. A recent review summarized these potential mechanisms, including:
shared neurotransmitter pathways; mutual impact on cognitive processes such as threat appraisal and catastrophizing; and a cycle of behavioral changes, including reduced activity and subsequent increases in pain and depressive symptoms. 10 Some researchers have even suggested that the presence of both pain and depression might be more accurately conceptualized as a "depression-pain syndrome" rather than the presence of two independent disorders. 11 In addition to possible shared etiology, there is also evidence that the co-occurrence of pain and depression is clinically significant. For instance, the extant literature suggests that persons with both chronic pain and depression experience greater disability than do persons with only chronic pain or depression. 10, 12 Their comorbidity also has implications for treatment: research in other populations has shown that both conditions may reduce treatment responsiveness in the other condition. 10, [13] [14] [15] While evidence exists that both chronic pain and depression are common among persons with history of TBI and that the co-occurrence of pain and depression is clinically important, we are not aware of any studies examining the comorbidity of pain and depression among persons with history of TBI. A recent systematic review of studies investigating pain among persons with TBI reported that "low grade" evidence exists for an association between depression and pain in persons with TBI. 16 If it were the case that pain and depression occur relatively independently of each other among persons with TBI, it would follow that pain and depression are separate constructs that can be assessed and treated independently in this population. Conversely, evidence of pain and depression being highly comorbid in persons with TBI would suggest that the interplay of pain and depression is similar to that observed in the general population. Such findings would highlight the importance of further research examining how best to assess and treat both conditions in this population.
To investigate these questions, we examined the co-occurrence of pain and depression in a cohort of participants with moderate to severe TBI both during inpatient rehabilitation and at 1-year post injury. Given that the first year after TBI is typically an active time of recovery and change in functioning, we were interested in exploring whether and how the frequency of, and association between, pain and depression might change over time. Based on existing literature, our hypotheses were that, at both time points, persons with pain would be more likely to be depressed and persons with depression would be more likely to have pain.
Methods
Subjects
Participants were part of a larger study of individuals enrolled into the University of follow up. The remaining 27 participants were unable to complete the specific measures necessary for the current analyses due to time constraints. Data from this study have been previously used to describe sleep and co-occurring psychological conditions after TBI, 18 but the data utilized for the analyses that follow have not been previously reported. All study procedures for the TBIMS and additional measures were approved by the University of Washington Human Subjects Review Committee, and informed consent was obtained from each participant.
Measures
Pain: 0-10 Numeric Rating Scale. Participants were asked to rate their overall pain, acknowledging that they may have pain in multiple locations using the Analog Pain Scale. Three questions about pain were asked: 1) overall average intensity of pain during the past week 2)
worst pain over the past week, and 3) current pain on a 0 -10 Numerical Rating Scale (NRS), with 0 = "No pain" and 10 = "Pain as bad as could be." These ratings were averaged to create a "characteristic pain score" that has been shown to be a valid and reliable measure of pain intensity. 19, 20 In the present study, and consistent with research on persons with other types of pain, [21] [22] [23] participants with an average score of ≥ 4 were considered to have at least moderate pain..
Depression: Patient Health Questionnaire-9 (PHQ-9).
The PHQ-9 is a commonly used measure of depression in medical populations 24 and has been validated in TBI populations. 25 Consistent with published guidelines, in the present study, participants who scored ≥ 10 were classified as "depressed."
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Data analysis
Using the cutoffs for pain and depression described above, descriptive statistics were computed to identify frequencies of pain alone, depression alone, comorbid pain and depression, and neither pain nor depression at both baseline and year 1. A Fisher Exact test was conducted for each time point to test for associations between pain and depression. We also calculated the relative risk that (a) a participant with depression would have pain relative to a participant without depression and (b) a participant with pain would have depression relative to a participant without pain. Finally, for the 116 participants for whom both pain and depression data were available at both time points, we conducted a subgroup analysis investigating the frequency of pain and depression at year 1 within each of the four baseline depression/pain status categories.
Results
Demographics
Demographic and injury characteristics of the sample at baseline (N = 158) and year 1 (N = 116) are displayed in Table 1 . Of note, complete data on pain and depression were available for only 73% of participants at year 1. Participants who did not complete the year 1 assessment had received, on average, fewer years of education, were more likely to be of non-Caucasian race, and were less likely to have been competitively employed prior to injury. Importantly, there were no significant differences on baseline rates of pain and depression between participants who completed all measures at year 1 and those who did not. Table 2 displays the prevalence of pain, depression, and the co-occurrence of pain and depression at baseline and year 1. The majority of participants (70%) reported experiencing at least moderate pain at baseline (> 4). Notably, the proportion of participants reporting at least moderate pain decreased to 34% at year 1. At both time points, depression was somewhat less prevalent in comparison to pain, with 31% of participants reporting depression at baseline and only 22% at year 1. The proportion of participants reporting comorbid pain and depression also decreased over time from 27% at baseline to 18% at year 1. These decreases in participants reporting depression and pain across time corresponded to a large increase in the proportion of participants reporting neither pain nor depression at Year 1.
Depression & Pain
Relative risk was calculated at each time point to examine the possibility that being classified as having pain might confer an increased likelihood of being classified as having depression and vice versa. A Fisher Exact test was conducted to test the significance of these associations. As shown in Table 2 , at baseline there was a statistically significant relationship between pain and depression: participants who reported pain were 1.37 times more likely to report depression and participants who reported depression were 2.62 times more likely to report pain (p < .003). The magnitude of this association was larger at year 1: participants who reported pain were 3.83 times more likely to report depression and participants who reported depression were 7.98 times more likely to report pain (p < .001) Table 3 The current findings are generally consistent with the extant literature on the comorbidity of pain and depression in the general population. This literature suggests that the conditions are often comorbid but that they are also independent problems with many persons suffering from just one or the other condition. 9 Hence, it is important for clinicians to be aware of potential comorbidity in persons with TBI and to carefully assess for depression when pain is present and vice versa. Existing research in the general population underscores the need to coordinate identification and management of these two conditions given their high comorbidity and the potential risk of failing to recognize depression as a possible contributor to somatic symptoms (e.g., fatigue, insomnia) that persons with pain (and TBI) often report. 10 The current results point to the highest incidence of comorbid depression and pain occurring early on in the course of recovery from TBI. However, although the proportion of persons suffering from both conditions declined between assessments, the linkage between the conditions actually grew over time.
These findings highlight the importance of assessing pain and depression on repeated occasions over the course of recovery from TBI in both clinical and research settings.
In light of the current results, further research investigating the potential mechanisms (e.g., behavioral, cognitive, neurophysiological) underlying this comorbidity among persons with TBI is warranted. Future research may benefit from measuring both depression and pain repeatedly over time to examine their reciprocal relationship and determine whether changes in one variable are predictive of changes in the other. One study that examined the reciprocal relationship between depression and functional limitations following TBI found that functional limitations predicted depression over time whereas depression did not predict functional limitations over time, suggesting that treating functional limitations may be paramount for addressing depression in persons with TBI. 26 If such a pattern were revealed between pain and depression over time among persons with TBI, it would be critical in guiding treatment recommendations and planning. It may also prove fruitful to explore trajectories or classes of people who respond more and less positively to treatment for pain, depression, and pain and depression combined so that increasingly targeted treatments can be developed and the effective allocation of treatment resources can be maximized.
Limitations
Given that the sample was drawn from one treatment center and was relatively homogenous with regard to ethnic composition, there are possible limitations to generalizability of the results. In addition, all participants had suffered recent injuries, received inpatient rehab, and received treatment in an academic medical center, which may mean participants received a different level of inpatient care and outpatient follow up care than would be available in many areas. Finally, those subjects who did not complete all measures at one year may have experienced additional psychosocial difficulties which could lead to an underestimation of pain and depression at that time period.
Conclusions
Despite these limitations, the current research provides critical data regarding the prevalence of pain and depression and their comorbidity among persons with TBI. The results indicate that the conditions are both prevalent and often comorbid. However, while the prevalence of both conditions diminished over the follow-up period, the association between the two conditions actually became stronger over time, suggesting that it is essential to be aware of potential comorbidity throughout the course of recovery from TBI. Future research will be essential for developing an increasingly nuanced understanding of the interplay of these conditions over time and their impact on treatment outcomes. * Pain defined as APS characteristic pain score ≥ 4 † Depression defined as PHQ-9 score ≥ 10. ‡ Relative risk was computed to describe the likelihood that 1) a participant classified as having depression would also be classified as having pain (relative to a participant without depression), and b) a participant classified as having pain would also be classified as having depression (relative to a participant without pain). 
